CHADDS FORD, PA — MOBILion Systems, Inc. announced that its groundbreaking Structures for Lossless Ion Manipulation (SLIM) technology has now been featured in 100 peer-reviewed publications. This achievement, reached as of December 2024, underscores the significant role SLIM has played in advancing separation science and driving innovation across multiple industries.
The SLIM platform, initially developed by Dr. Richard D. Smith at Pacific Northwest National Laboratory in 2014, became a game-changer in molecular separation. It has enabled faster, more accurate, and more efficient workflows in liquid chromatography-mass spectrometry, earning recognition in top scientific journals such as Journal of the American Society for Mass Spectrometry, Analytical Chemistry, and International Journal of Mass Spectrometry.
The technology’s versatility is evident in its applications, which range from drug discovery and biomarker research to clinical studies, environmental analysis, food safety, and forensic science. SLIM has also proven invaluable for characterizing complex compounds such as perfluorinated chemicals and natural products.
“These publications are a testament to the transformative impact of the SLIM platform technology to shift the paradigm of what is possible in analytical characterization by improving traditional liquid chromatography-mass spectrometry workflows with faster, more efficient, deeper, and more accurate molecular characterization,” said Melissa Sherman, Ph.D., CEO of MOBILion Systems.
Dr. Sherman emphasized the technology’s broad implications, stating, “The MOBILion team is honored to have the exclusive opportunity to harness and evolve Dr. Smith’s visionary invention and deliver a portfolio of robust products with breadth of functionality that radically advances separation science. We are driven to provide capabilities to researchers to spur new scientific insights across diverse disciplines.”
MOBILion continues to build on SLIM’s foundation with its first commercial offering, the MOBIE®-QTOF platform, and is actively developing PAMAF operation mode to handle even more complex molecular analyses.
“We are proud to have translated this incredible science into commercial products that are driving real-world advancements and are available to the masses,” Dr. Sherman added. “This journey from innovation to impact has been extraordinary. With the MOBIE®-QTOF platform as our first commercial product and the PAMAF operation mode for more complex analysis in development, we are excited to continue pushing the boundaries of separation science to unlock new growth and innovation opportunities across multiple industries.”
This milestone marks a pivotal moment not only for MOBILion Systems but also for the broader field of analytical science. The SLIM platform’s demonstrated success reaffirms its position as a vital tool in addressing complex scientific challenges, enabling researchers to achieve unprecedented levels of molecular insight.
Explore the research in the full list of publications here and additional scientific resources on on MOBILion’s official website.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.